Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tolinapant by Astex Pharmaceuticals for T-Cell Leukemia: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase II for T-Cell Leukemia. According to GlobalData, Phase...
Tolinapant by Astex Pharmaceuticals for Glioblastoma Multiforme (GBM): Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
Tolinapant by Astex Pharmaceuticals for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...
Tolinapant by Astex Pharmaceuticals for T-Cell Lymphomas: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...
Tolinapant by Astex Pharmaceuticals for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase II for Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. According...
Tolinapant by Astex Pharmaceuticals for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL). According...
Tolinapant by Astex Pharmaceuticals for Head And Neck Cancer: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Head And Neck Cancer. According to...
Tolinapant by Astex Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Tolinapant by Astex Pharmaceuticals for Hepatocellular Carcinoma: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase...
Tolinapant by Astex Pharmaceuticals for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Tolinapant by Astex Pharmaceuticals for Metastatic Colorectal Cancer: Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
Tolinapant by Astex Pharmaceuticals for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Tolinapant is under clinical development by Astex Pharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2...